Topamax birth defect claims are being investigated across the country as parents may be unknowingly exposing infants to the anticonvulsant drug in utero, possibly increasing the risk of major birth defects. Topamax is an anticonvulsant medication manufactured by Johnson & Johnson and approved by the FDA in 1996 to treat individuals suffering from epilepsy and migraine headaches. The Consumer Justice Foundation has developed http://www.topamaxbirthinjury.com to help parents that have given birth to children with birth defects and have taken anticonvulsants such as Topamax during pregnancy seek legal recourse.
via news.yahoo.com
No comments:
Post a Comment